MedPath

vitamin A effect on post bronchiolitis wheezing

Phase 2
Conditions
Condition 1: Bronchiolitis. Condition 2: Post Bronchiolitis Wheezing.
Acute bronchiolitis, unspecified
Wheezing
Registration Number
IRCT20180425039418N5
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Infants with a history of upper respiratory tract infection (runny nose - cough) with increased respiratory effort and abnormal auditory findings.
Acquiring informed consent of parents
Being Term at birth
Normal weight at birth and during admission
Not having chronic or congenital lung, cardiac, neurological diseases and immune deficiency
No vitamin A intake before entering to the study

Exclusion Criteria

Other diagnoses for the patients during admission
Parental dissatisfaction to continue participating in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of wheezing in bronchiolitis. Timepoint: At 24 hours after the injection (during the patient's hospitalization), during discharge and two weeks after discharge. Method of measurement: Littmann Stethoscope 3M.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath